id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S5244 R13564 |
Greenup (Controls exposed to lamivudine), 2014 | Abnormal APGAR < 8 (5min) | 2nd and/or 3rd trimester | prospective cohort | exposed to other treatment, sick excluded | Adjustment: No Control group: Lamivudine Exposed group: TDF (only) Indication: CHB |
0.91 [0.02;46.84] C excluded (control group) |
0/58 0/53 | 0 | 58 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5243 R13554 |
Greenup (Controls unexposed, sick), 2014 | Abnormal APGAR < 8 (5min) | 2nd and/or 3rd trimester | prospective cohort | unexposed, sick | Adjustment: No Control group: Unexposed, sick Exposed group: TDF (only) Indication: CHB | 0.11 [0.00;2.75] C | 0/58 1/20 | 1 | 58 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 1 studies | 0.11 [0.00;2.75] | 1 | 58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Controls unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 5244